Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.

PubWeight™: 1.84‹?› | Rank: Top 3%

🔗 View Article (PMID 24700706)

Published in Circulation on April 03, 2014

Authors

Marie-Claude Morice1, Patrick W Serruys2, A Pieter Kappetein2, Ted E Feldman2, Elisabeth Ståhle2, Antonio Colombo2, Michael J Mack2, David R Holmes2, James W Choi2, Witold Ruzyllo2, Grzegorz Religa2, Jian Huang2, Kristine Roy2, Keith D Dawkins2, Friedrich Mohr2

Author Affiliations

1: From the Institut Cardiovasculaire Paris Sud, Hopital Privé Jacques Cartier, Générale de santé, Massy, France (M.-C.M.); Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands (P.W.S., A.P.K.); Evanston Hospital, Evanston, IL (T.E.F.); University Hospital Uppsala, Uppsala, Sweden (E.S.); San Raffaele Scientific Institute, Milan, Italy (A.C.); Medical City Hospital, Dallas, TX (M.J.M.); Mayo Clinic, Rochester, MN (D.R.H.); Baylor Heart and Vascular Hospital, Dallas, TX (J.W.C.); Institute of Cardiology, Warsaw, Poland (W.R., G.R.); Boston Scientific Corporation, Natick, MA (J.H., K.R., K.D.D.); University of Leipzig Heart Center, Leipzig, Germany (F.M.). mc.morice@icps.com.fr.
2: From the Institut Cardiovasculaire Paris Sud, Hopital Privé Jacques Cartier, Générale de santé, Massy, France (M.-C.M.); Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands (P.W.S., A.P.K.); Evanston Hospital, Evanston, IL (T.E.F.); University Hospital Uppsala, Uppsala, Sweden (E.S.); San Raffaele Scientific Institute, Milan, Italy (A.C.); Medical City Hospital, Dallas, TX (M.J.M.); Mayo Clinic, Rochester, MN (D.R.H.); Baylor Heart and Vascular Hospital, Dallas, TX (J.W.C.); Institute of Cardiology, Warsaw, Poland (W.R., G.R.); Boston Scientific Corporation, Natick, MA (J.H., K.R., K.D.D.); University of Leipzig Heart Center, Leipzig, Germany (F.M.).

Associated clinical trials:

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries (SYNTAX) | NCT00114972

Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival (SYNTAXES) | NCT03417050

Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation Lesions (DR vs DK crush) | NCT05258318

Articles citing this

Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Clin Res Cardiol (2015) 0.78

Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal. J Am Heart Assoc (2015) 0.76

Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression. BMJ Open (2015) 0.75

Stenting or bypass surgery for unprotected left main coronary artery disease-still a long rally to go. J Thorac Dis (2016) 0.75

Coronary artery disease: Similar 5-year outcomes with CABG surgery or PCI for left main disease. Nat Rev Cardiol (2014) 0.75

The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.75

The role of coronary artery bypass grafting in patients with ischemic cardiomyopathy in the current era. J Thorac Dis (2016) 0.75

Effect of coronary artery revascularization on in-hospital outcomes and long-term prognoses in acute myocardial infarction patients with prior ischemic stroke. J Geriatr Cardiol (2016) 0.75

PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials. J Thorac Dis (2017) 0.75

Left Internal Mammary Artery Versus Coronary Stents: Impact on Downstream Coronary Stenoses and Conduit Patency. J Am Heart Assoc (2016) 0.75

Does Higher Spending Improve Survival Outcomes for Myocardial Infarction? Examining the Cost-Outcomes Relationship Using Time-Varying Covariates. Health Serv Res (2015) 0.75

"You don't need a weather man to know which way the wind blows": understanding differences and applications in clinical practice of randomized controlled trials on unprotected left main. Ann Transl Med (2017) 0.75

Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis. BMC Med (2017) 0.75

Very long-term follow-up for left main coronary artery stenting: a missing piece of the jigsaw puzzle. J Thorac Dis (2016) 0.75

Percutaneous coronary intervention versus bypass grafting in left main coronary artery disease. J Thorac Dis (2016) 0.75

Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A meta-analysis. PLoS One (2017) 0.75

Impact of left main coronary artery disease on long-term mortality in patients undergoing drug-eluting stent implantation. Clin Res Cardiol (2017) 0.75

Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials. PLoS One (2017) 0.75